{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/11/3342640/0/en/rhythm-pharmaceuticals-announces-imcivree-setmelanotide-receives-expanded-marketing-authorization-in-the-united-kingdom-for-treatment-of-obesity-and-control-of-hunger-in-patients-w.html", "message": "News view counter 875132 successfully enlarged"}